PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 20, 2026American Journal of Respiratory and Critical Care Medicine0 citations

Clinical Outcomes of Non-Cystic Fibrosis Bronchiectasis Patients

B45-01 Clinical Outcomes of Patients With Non-Cystic Fibrosis Bronchiectasis

View Full Paper
Ask AI
Bookmark
Share

Authors

AFA G FerreiraPPP De Oliveira Alcantara PaniagoIFI Akel de Faria

Discussion

Loading...

Member takes

Overview

Retrospective cohort study analyzes outcomes in patients with non-cystic fibrosis bronchiectasis, suggesting azithromycin reduces exacerbations.

Key Points

  • The aim was to evaluate the clinical profile and outcomes of patients with non-cystic fibrosis bronchiectasis.
  • Retrospective single-center cohort study of 75 patients with non-cystic fibrosis bronchiectasis
  • Data collected included sociodemographic information, comorbidities, symptoms, medications, spirometry results, and sputum cultures
  • Statistical analyses included Mann-Whitney and Kruskal-Wallis tests for comparisons and chi-square tests for associations.
  • Continuous use of azithromycin significantly reduced exacerbations (chi-square=7.89, p=0.005)
  • Sputum culture positivity was not significantly related to sputum color (chi-square=3.77, p=0.288)
  • Chronic infection showed a significant association with sputum color (chi-square=8.72, p=0.033).

Cite This Study

Ferreira et al. (2026) studied this question.

synapsesocial.com/papers/6a0d4f92f03e14405aa9af1ahttps://doi.org/10.1093/ajrccm/aamag162.1229
View Full Paper
Ask AI
Bookmark
Share